(Q43134211)

English

Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients

scientific article published on 10 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

Ryuhei Hara

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Takahiro Kawaji

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Yasuya Inomata

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Jin Tahara

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Nina Sagara

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Mikiko Fukushima

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Hidenobu Tanihara

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

10 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

248

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

931-936

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1343-8

21 January 2018

Guidelines for PDT in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1343-8

21 January 2018

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1343-8

21 January 2018

Current concepts in the pathogenesis of age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for the treatment of choroidal neovascularization due to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polypoidal choroidal vasculopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of polypoidal choroidal vasculopathy with photodynamic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20221623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-010-1343-8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43134211&oldid=2205816225"